SRRK - Scholar Rock Holding Corporation
About Scholar Rock Holding Corporation (https://scholarrock.com)
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is also developing a pipeline of novel product candidates with potential to transform the lives of patients suffering from a range of serious diseases, including neuromuscular disorders, cancer, and fibrosis. The company has a collaboration agreement with Gilead Sciences, Inc. to discover and develop specific inhibitors of transforming growth factor beta activation for the treatment of fibrotic diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| David L. Hallal | Chief Executive Officer & Chairman of the Board | 1966 | $3,157,439 USD |
| Akshay K. Vaishnaw | President of R&D, Member of Scientific Advisory Board and Director | 1963 | $2,833,966 USD |
| Akshay Krishnadas Vaishnaw | President of R&D, Member of Scientific Advisory Board and Director | 1963 | $2,833,966 USD |
| Robert Keith Woods | Chief Operating Officer | 1968 | $1,107,060 USD |
| Vikas Sinha | CFO & Treasurer | 1963 | $1,063,909 USD |
| Jing L. Marantz | Chief Medical Officer | 1965 | $755,185 USD |
| Mo Qatanani | Chief Scientific Officer | 1973 | $704,681 USD |
| Junlin | General Counsel & Corporate Secretary | 1979 | $563,729 USD |
| Caryn Parlavecchio | Chief Human Resources Officer | 1972 | – |
| Erin Moore | Interim Principal Financial & Accounting Officer | 1975 | – |
| Lisa Amaya Price | Senior Vice President of Human Resources | – | – |
| Lisa Wyman | Chief Technical & Quality Officer | 1978 | – |
| Rebecca McLeod | Chief Brand Officer & GM of U.S. | – | – |
| Rushmie Nofsinger | Vice President of Corporate Affairs & Investor Relations | – | – |
| Ryan Iarrobino | Senior Vice President of Clinical Development & Operations | – | – |